NICE wants more rifaximin data for hepatic encephalopathy

The U.K.'s NICE said it is "minded not to recommend" Targaxan rifaximin from Norgine B.V. (Amsterdam, the Netherlands) to reduce recurrence of episodes of overt hepatic encephalopathy (HE) in adults, ...